differential effects of high-carbohydrate and high-fat diets on hepatic lipogenesis in rats
TRANSCRIPT
ORIGINAL CONTRIBUTION
Differential effects of high-carbohydrate and high-fat dietson hepatic lipogenesis in rats
Alessandra Ferramosca • Annalea Conte •
Fabrizio Damiano • Luisa Siculella •
Vincenzo Zara
Received: 10 July 2013 / Accepted: 22 October 2013
� Springer-Verlag Berlin Heidelberg 2013
Abstract
Purpose Hepatic fatty acid synthesis is influenced by
several nutritional and hormonal factors. In this study, we
have investigated the effects of distinct experimental diets
enriched in carbohydrate or in fat on hepatic lipogenesis.
Methods Male Wistar rats were divided into four groups
and fed distinct experimental diets enriched in carbohy-
drates (70 % w/w) or in fat (20 and 35 % w/w). Activity
and expression of the mitochondrial citrate carrier and of
the cytosolic enzymes acetyl-CoA carboxylase and fatty
acid synthetase were analyzed through the study with
assessments at 0, 1, 2, 4, and 6 weeks. Liver lipids and
plasma levels of lipids, glucose, and insulin were assayed
in parallel.
Results Whereas the high-carbohydrate diet moderately
stimulated hepatic lipogenesis, a strong inhibition of this
anabolic pathway was found in animals fed high-fat diets.
This inhibition was time-dependent and concentration-
dependent. Moreover, whereas the high-carbohydrate diet
induced an increase in plasma triglycerides, the high-fat
diets determined an accumulation of triglycerides in liver.
An increase in the plasmatic levels of glucose and insulin
was observed in all cases.
Conclusions The excess of sucrose in the diet is con-
verted into fat that is distributed by bloodstream in the
organism in the form of circulating triglycerides. On the
other hand, a high amount of dietary fat caused a strong
inhibition of lipogenesis and a concomitant increase in the
level of hepatic lipids, thereby highlighting, in these con-
ditions, the role of liver as a reservoir of exogenous fat.
Keywords Fatty acid synthesis � Mitochondrial
citrate carrier � Lipogenic enzymes
Introduction
Hepatic lipogenesis is strictly regulated by a series of
hormonal and nutritional factors [1, 2]. In particular, the
effect of distinct nutrients and/or of different combinations
of them in experimental diets has been studied both in
animal models and in humans. It has been found that a diet
enriched in carbohydrate is capable of stimulating hepatic
fatty acid synthesis, thereby channelling the excess of
acetyl units deriving from glucose catabolism toward fat
biosynthesis in liver [1, 3]. On the contrary, a diet enriched
in fat generally decreases hepatic fatty acid synthesis even
if the final effect of this dietary treatment strongly depends
on the type and the amount of fat ingested [4–6]. In fact, a
diet enriched in polyunsaturated fatty acids (PUFA)
inhibits hepatic fatty acid synthesis more strongly than a
diet enriched in monounsaturated fatty acids (MUFA) or
saturated fatty acids (SFA) that, under certain conditions,
appear almost without effect. Furthermore, more fat is
ingested and higher inhibition of hepatic fatty acid syn-
thesis is found. All these effects imply the modulation of
several enzyme activities and are dependent on a differ-
ential gene expression induced by dietary fat.
The excess of carbon units introduced by hypercaloric
diets and mainly deriving from carbohydrates can be
addressed toward the anabolic pathway of hepatic fatty
acid synthesis. In this way, the excess of dietary energy is
stored as fat. However, the metabolic conversion of
A. Ferramosca � A. Conte � F. Damiano � L. Siculella �V. Zara (&)
Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali,
Universita del Salento, Via Provinciale Lecce-Monteroni,
73100 Lecce, Italy
e-mail: [email protected]
123
Eur J Nutr
DOI 10.1007/s00394-013-0613-8
carbohydrates into fatty acids involves a complex series of
reactions located in different subcellular compartments.
The mitochondrial acetyl-CoA deriving from catabolism is
at first condensed with oxaloacetate, thereby forming cit-
rate. This tricarboxylate is transported outside mitochon-
dria by the citrate carrier (CIC) [7, 8], an integral protein of
the inner mitochondrial membrane, and once in the cytosol
is again converted into acetyl-CoA and oxaloacetate by the
ATP citrate lyase. The cytosolic acetyl-CoA is then the
starter of hepatic fatty acid synthesis catalyzed by acetyl-
CoA carboxylase (ACC) and fatty acid synthetase (FAS).
In this anabolic pathway, an interesting role is played by
the CIC, which represents the only way to ensure that the
excess of carbon units produced in mitochondria is
addressed toward cytosolic biosynthesis. The CIC cata-
lyzes an electroneutral exchange of a tricarboxylate (cit-
rate, isocitrate, or cis-aconitate) plus a proton for a
dicarboxylate (malate or succinate) or phosphoenolpyr-
uvate, but the substrates transported and the direction of
fluxes across the inner mitochondrial membrane depend on
the metabolic state of the organism [9].
The information on the effect of various experimental
diets on hepatic fatty acid synthesis is extensive but, at the
same time, fragmentary and/or partially inconsistent. This
is mainly due to the very large variety of experimental
conditions used in the multitude of nutritional studies
carried out on this topic. We have therefore investigated
the effects of high-carbohydrate or high-fat diets on hepatic
lipogenesis using the same experimental conditions and the
same animal model. Moreover, besides the changes in the
activities and the expression of the cytosolic lipogenic
enzymes ACC and FAS, we have also investigated the
transport activity and the expression of the mitochondrial
CIC, a member of the mitochondrial carrier family [9, 10].
The picture emerging from this investigation shows not
only an elegant flexibility of hepatic fatty acid synthesis in
strict dependence on the experimental diets but also a
prompt and concerted modulation of mitochondrial and
cytosolic reactions.
Materials and methods
Animals and diets
Male Wistar rats (150–200 g) were obtained from Harlan
and housed individually in animal cages at a temperature of
22 ± 1 �C with a 12/12-h light–dark cycle and 30–40 %
humidity. After acclimatization, animals were divided into
four groups and fed with different diets for various time
periods, ranging from 1 to 6 weeks (Table 1). The first
group (control group) received a standard natural-ingredi-
ent diet, also known as standard rodent chow, containing
6.2 % (w/w) fat and 44.2 % (w/w) carbohydrate (5 % w/w
sucrose). The second group (HC group) received a diet
with 70 % (w/w) carbohydrate (66 % w/w sucrose) and an
almost equivalent amount of fat (5.2 % w/w). The third
group (HF group) was fed with a diet containing a higher
content of fat (20.2 % w/w fat) and a concomitant lower
amount of carbohydrate (45.5 % w/w). This diet was made
with a mixture of beef tallow plus hydrogenated fat, and as
a consequence, it contains a relatively high content of trans
fatty acids (17 % of total fatty acids). Approximate fatty
acid profile of this diet was as follows: 41 % saturated,
52 % monounsaturated, and 7 % polyunsaturated fatty
acids. The fourth group (HHF group) received a diet with
35.2 % (w/w) fat (exclusively lard) and 36.1 % (w/w)
carbohydrate. Approximate fatty acid profile of this diet
was as follows: 40 % saturated, 50 % monounsaturated,
and 10 % polyunsaturated fatty acids. Animals were
allowed ad libitum access to diet and water. At the
beginning of dietary treatment (week 0) and after 1, 2, 4,
and 6 weeks, rats were killed by decapitation, according to
the guidelines for the care and use of laboratory animals.
Body weight, liver weight, and food intake were recorded
throughout the study, ranging from 1 to 6 weeks of dietary
treatment. For the determination of plasma lipid, glucose,
and insulin, control and treated rats were starved overnight
before killing. Blood was collected and centrifuged to
separate plasma. Glucose concentration was determined
using a commercial kit. Plasma insulin concentration was
analyzed with an enzyme-linked immunosorbent assay kit.
Table 1 Composition of experimental diets
Control HC
diet
HF
diet
HHF
diet
Protein (g/100 g) 18.6 17.7 20.9 20.4
Fat (g/100 g) 6.2 5.2 20.2 35.2
Fatty acids (%)
SFA 16.0 15.0 41.0 40.0
MUFA 23.0 23.0 52.0 50.0
PUFA 61.0 62.0 7.0 10.0
Carbohydrate (g/100 g) of
which sucrose
44.2 70.0 45.5 36.1
5.0 66.0 18.2 15.0
kcal/g 3.1 4.0 4.5 5.4
Calories from protein (%) 24.0 17.8 18.7 15.0
Calories from fat (%) 18.0 11.8 40.6 58.4
Calories from carbohydrates
(%)
58.0 70.4 40.7 26.6
Control animals received a standard diet (Global Diet 2018S from
Harlan Teklad). The HC group received a diet with 70 % carbohy-
drate (Diet TD.98090 from Harlan Teklad), the HF group was fed
with an adjusted fat (20.2 % fat) diet (Diet TD.96132 from Harlan
Teklad), and the HHF group received a diet with 35.2 % fat (Diet
TD.03584 from Harlan Teklad). Energy content was calculated using
4 kcal/g for protein and carbohydrate, and 9 kcal/g for lipid
Eur J Nutr
123
Citrate transport in rat liver mitochondria
Rat liver mitochondria were prepared by standard pro-
cedures, and mitochondrial protein concentration was
determined by the Bradford method [11]. Freshly iso-
lated mitochondria were resuspended in 100 mM KCl,
20 mM Hepes, 1 mM EGTA, 2 lg/ml rotenone, pH 7.0,
at a concentration of about 5 mg protein/ml, and loaded
with L-malate. The assay of citrate transport, carried out
at 9 �C, was initiated by the addition of 0.5 mM
[14C]citrate and stopped by 12.5 mM 1,2,3-BTA. Rat
liver mitochondria were reisolated at 18,000 g for
10 min, washed, and then extracted with 20 % HClO4.
The mixture was centrifuged, and the radioactivity
present in the supernatant was counted by liquid
scintillation.
Reconstitution of the citrate transport into liposomes
Rat liver mitochondria (10–15 mg protein) were solubi-
lized with a buffer containing 3 % Triton X-100 (w/v),
20 mM Na2SO4, 1 mM EDTA, 10 mM Pipes, pH 7.0, at
a final concentration of about 10 mg protein/ml. After
incubation for 10 min on ice, the mixture was centri-
fuged at 25,000g for 20 min at 2 �C. About 600 ll of
the supernatant (mitochondrial extract) was supplemented
with 2 mg/ml cardiolipin, chromatographed onto a cold
hydroxyapatite column (pasteur pipette containing
600 mg of dry material), and eluted with a buffer con-
taining 0.5 % Triton X-100 and 5 mM citrate/NaOH, pH
7.0. The first 600 ll of the eluate was pooled and used
for the reconstitution experiments; protein concentration
was determined using the Lowry method modified for
the presence of Triton [12].
The composition of the initial mixture used for
reconstitution was as follows: 50 ll of hydroxyapatite
eluate, 90 ll of 10 % Triton X-114, 20 ll of 20 mg/ml
cardiolipin, 100 ll of 10 % phospholipids in the form of
sonicated liposomes, 70 ll of 100 mM Pipes (pH 7.0),
and 35 ll of 200 mM citrate in a final volume of 700 ll.
After vortexing, this mixture was passed 15 times
through the same Amberlite XAD-2 column, in order to
obtain the proteoliposomes. The external citrate was
removed by gel filtration on a Sephadex G-75 column.
The first 600 ll of the turbid eluate was collected, dis-
tributed in reaction vessels (180 ll), and used for the
transport studies. Transport at 25 �C was started by
adding 0.5 mM [14C]citrate (unless otherwise indicated)
to the proteoliposomes and terminated by the addition of
20 mM 1,2,3-BTA. The external radioactivity was
removed on Dowex AG1-X8 columns, and the internal
radioactivity was measured by scintillation counting.
Assay of lipogenic enzymes
The enzymatic activities of ACC and FAS were determined
spectrophotometrically in rat liver cytosol. Cytosol was
obtained by centrifuging the post-mitochondrial superna-
tant at 20,000g for 20 min at 2 �C. The pellet was dis-
carded, and the supernatant was then centrifuged at
105,000g for 60 min. The activities of ACC and FAS were
measured in the resulting cytosol as previously described,
using a NADH- and NADPH-linked assay, respectively
[13].
Western blot analysis
Polyacrylamide gel electrophoresis was performed in the
presence of 0.1 % SDS (SDS–PAGE) according to the
standard procedures. The mitochondrial proteins, separated
by SDS–PAGE, were then transferred to nitrocellulose
membrane. For protein detection, antisera prepared in our
laboratory and directed against the C-terminus of the rat
liver CIC and against the mammalian porin were used at a
dilution of 1:3 9 103. The immunoreacted proteins were
detected by the peroxidase reaction, using N, N0 Diamino
Benzydine (DAB) and hydrogen peroxide.
Isolation of RNA from rat liver and real-time qPCR
analysis
Total RNA extraction from rat liver was performed as
described in [14]. Quantitative gene expression analysis was
performed (SmartCycler System, Cepheid) using SYBR
Green technology (FluoCycle, Euroclone) and 18S rRNA for
normalization. The primers used for real-time PCR analysis
were the following: CICfor (50-GCCTCAGCTCCTTG
CTCTA-30); CICrev (50-ACTACCACTGCCTCTGCCA-30);FASfor (50-CTCTGGTGGTGTCTACATTTC-30); FASrev
(50-GAGCTCTTTCTGCAGGATAG-30); ACCFor (50-CTT
GGAGCAGAGAACCTTCG-30); ACCRev (50-CCTGG
ATGGTTCTTTGTCCC-30).
Assay of lipids
Total lipids were extracted from rat liver with a 1:1 mixture
of chloroform and methanol. The extracts were dried under
nitrogen flow and resuspended in a suitable volume of
0.1 % Triton X-100 before carrying out lipid analysis. The
individual assays of liver and plasma triglycerides, cho-
lesterol, and phospholipids were carried out using com-
mercial kits purchased from Futura System (Formello,
Italy; REF. N� 2703, 2049, 2302).
Eur J Nutr
123
Statistical analysis
GraphPad Prism� software version 5.0 (GraphPad Soft-
ware Inc., LA Jolla, CA, USA) was used for statistical
analyses. Data were confirmed to be normally distributed
by Anderson–Darling normality test (P [ 0.05). Values,
presented as the mean ± SD, were analyzed by one-way
ANOVA. A Tukey–Kramer post hoc analysis was used to
detect significant differences between the means at a level
of P \ 0.05.
Results
Food intake, body weight, and liver weight
As illustrated in Table 1, the increase in dietary fat was
compensated by a reduction in carbohydrate levels,
whereas the protein concentration was kept approximately
constant (around 20 % w/w) in all diets. Because of the
different caloric values of carbohydrate and lipid, the diets
slightly differed in this parameter, being 3.1, 4.0, 4.5, and
5.4 kcal/g for control, HC, HF, and HFF diet, respectively.
Furthermore, the approximate fatty acid profile (SFA,
MUFA, and PUFA) of both high-fat diets (HF and HFF)
was comparable and low in PUFA in order to prevent a
strong inhibitory effect of hepatic fatty acid synthesis by
these unsaturated fatty acids.
As shown in Table 2, food intake was approximately the
same in control, HC-, and HF-fed rats, whereas a small
decrease was seen in the case of the HFF-fed animals.
Because of the different caloric value of the diets, the kcal
introduced per day slightly increased passing from control
to HC-, HF-, and HFF-fed animals. However, these dif-
ferences were not statistically significant. With the excep-
tion of the first week, the body weight of the HC-fed rats
was practically similar to that of the control group
(Table 2). In the HF group, the body weight was signifi-
cantly higher in comparison with that of control animals in
the first two weeks of dietary administration. The HHF
animals showed a body weight significantly higher than
that of control rats at any time of dietary treatment. The
maximal increase in body weight in HHF animals was
around 20 % with respect to control rats (Table 2). Finally,
no statistically significant variations were found in the liver
weight of animals fed with the different experimental diets
(Table 2).
Hepatic fatty acid synthesis
Figure 1a shows the CIC transport activity measured in
freshly isolated liver mitochondria from rats fed the four
experimental diets. A small increase in the activity of
mitochondrial CIC (about 15–20 %) was found in HC-fed
animals when compared to control rats. This increase was
statistically significant at the fourth and the sixth week of
Table 2 Effect of dietary treatments on food intake, body weight, and liver weight
Food intake
Control HC HF HHF
Mean SD Mean SD Mean SD Mean SD
g/day 20.5 2.8 19.3 5.0 18.8 2.4 16.0 4.6
kcal/day 63.5 8.7 77.2 20.0 84.4 9.7 86.2 18.6
Body weight (g)
Week 0 234.0 7.8 – – –
Week 1 232.5 3.5 254.0* 14.1 281.3*� 15.7 282.3*� 10.5
Week 2 240.0 17.0 236.2 24.9 265.7*� 15.5 282.7*�� 6.2
Week 4 296.3 0.6 289.2 29.3 308.0 38.9 302.0* 22.2
Week 6 281.7 13.9 316.0 50.8 330.7 46.5 305.7* 21.6
Liver weight (g/100 g body weight)
Week 0 3.28 0.26 – – –
Week 1 3.85 0.57 4.18 0.61 3.70 0.91 3.58 0.57
Week 2 3.80 0.47 3.74 0.80 3.20 0.17 3.02 0.64
Week 4 3.90 0.63 3.53 0.70 3.15 0.57 3.01 0.40
Week 6 3.47 0.30 3.25 0.47 3.08 0.55 2.85 0.52
Food intake, body weight, and liver weight of rats fed with the experimental diets used in this study are shown for the times indicated. Each point
represents the mean ± SD for 4 animals
* P \ 0.05 versus rats fed a control diet; �P \ 0.05 versus rats fed a HC diet; �P \ 0.05 versus rats fed a HF diet
Eur J Nutr
123
dietary treatment. On the contrary, a statistically significant
decrease in the CIC activity was observed in HF animals at
the beginning of dietary treatment in comparison with both
control and HC group. The highest CIC inhibition in the
HF-fed rats was found at the first week (52.3 and 57.4 %
vs. control and HC, respectively). Interestingly, the HHF
group showed a higher CIC activity inhibition in compar-
ison with the HF group at the first week. In fact, at that
time, the CIC inhibition found in the HHF animals was
80.4 and 82.5 % in comparison with the control and the HC
group, respectively. It is noteworthy that the mitochondrial
CIC activity became indistinguishable in HF, HHF, and
control animal at longer dietary treatments (Fig. 1a, sixth
week).
To exclude a possible influence of the diet on the lipid
composition of the inner mitochondrial membrane in which
CIC operates, we purified the carrier protein and recon-
stituted its transport activity into liposomes. As shown in
Fig. 1b, the behavior of the CIC activity in the proteolip-
osomal system, which shows a definite lipid composition,
was very similar to that previously observed in intact rat
liver mitochondria. Very interestingly, at the first week of
dietary treatment, we found an inhibition of the CIC
transport activity higher than 80 % in HHF animals with
respect to both the control and the HC ones. It is also
remarkable the progressive quenching of the differences in
CIC activity over time. At the sixth week of dietary
treatment, the CIC activities were comparable in control,
HF, and HHF animals (Fig. 1b). Only a small yet signifi-
cant increase was still detectable in HC-fed rats in com-
parison with the other experimental groups.
Table 3 reports the analysis of the kinetic parameters
(Km and Vmax) of mitochondrial CIC activity in the
reconstituted system. No change in the affinity of the CIC
toward its substrate was detected at any time of dietary
treatment in any animal group. On the contrary, the vari-
ations in the Vmax values were consistent with the CIC
activities measured both in fresh mitochondria and in the
reconstituted system (Fig. 1a, b). Indeed, a small increase
in the Vmax of CIC was found in HC-fed rats in com-
parison with the control animals at any time of dietary
treatment. On the contrary, a strong decrease in the Vmax
was found in HF and HHF animals during the first 2 weeks
of dietary treatment.
Figure 2 shows a Western blot analysis of the mito-
chondrial membranes purified from the four groups of
animals and immunodecorated with an antiserum directed
against the rat liver CIC. The variations in the expression
of the mitochondrial CIC in each group of rats (Fig. 2a)
were consistent with those found in the CIC transport
activity previously shown in Fig. 1a, b. The analysis of the
CIC transcripts showed similar trends (Fig. 2b).
Figure 3a shows that the ACC activity slightly and
significantly increased in the HC-fed rats in comparison
with the control animals at any time of dietary treatment.
The extent of this increase (about 15–20 %) was compa-
rable to that found in the CIC activity in the same group of
animals. On the contrary, a strong and significant inhibition
was found in the HF- and HHF-fed rats at the first week of
dietary treatment in comparison with both control and HC-
fed rats (Fig. 3a). Again, this inhibition was progressively
reversed over time and nullified at the sixth week. As
expected, the FAS activity showed a behavior very similar
to that of ACC (Fig. 3b). Notably, the maximal inhibition
of ACC and FAS activity in HHF-fed animals in compar-
ison with the control ones was 77.5 and 74.3 %, respec-
tively. The decrease in the ACC and FAS activities was
further substantiated by the assay of AAC and FAS
mRNAs as shown in Fig. 3c, d, respectively.
MitochondriaA
Proteoliposomes
Control
B
Cit
rate
up
take
(nm
ol .
min
-1 . m
g p
rote
in-1
)C
itra
te u
pta
ke(n
mo
l . 1
0 m
in-1
. m
g p
rote
in-1
)
3
6
9
12
15
18
0 1 2 3 4 5 6
Weeks
HC
HF
HHF
50
100
150
200
250
300
350
0 1 2 3 4 5 6
Weeks
Control
HC
HF
HHF
Fig. 1 Effect of high-carbohydrate and high-fat diets on the transport
activity of mitochondrial CIC. Transport of citrate into rat liver
mitochondria (a) and into proteoliposomes (b) was measured at the
times indicated. The values reported in the figure represent the
mean ± SD (n = 4). *P \ 0.05 versus rats fed a control diet;�P \ 0.05 versus rats fed a HC diet; �P \ 0.05 versus rats fed a HF
diet
Eur J Nutr
123
Plasma and liver lipids
Table 4 shows that plasma triglycerides strongly and sig-
nificantly increased in HC-fed rats in comparison with the
control animals. The highest increment in plasma triglyc-
erides was detected in the HC group at the first week
(?2.3-fold vs. control group). A moderate, yet significant,
increment in plasma triglyceride levels was also found in
HF-fed rats in comparison with the control animals.
Notably, the HHF-fed rats showed a high peak in the tri-
glyceride levels at the first week of dietary treatment
(?2.1-fold vs. control group), followed by lower values at
longer feeding times (Table 4). The assay of plasma cho-
lesterol did not reveal any significant variation among the
different dietary groups except for a small yet significant
increase in the cholesterol level in the HHF-fed animals at
the first week of dietary treatment (?26.8 % with respect to
control) (data not shown). In the case of plasma phospho-
lipids (data not shown), statistically significant variations
were found only in the first week of dietary treatment. The
following increments were indeed found: ?34.8 % (HC
group), ?57.2 % (HF group), and ?75.3 % (HHF group)
with respect to control animals.
Figure 4a shows that the triglyceride levels strongly
increased in liver of HHF-fed rats in comparison with the
control rats at any time of dietary treatment. In particular, the
highest increments (around ?2.5-fold) were found starting
from the second week up to the sixth week of dietary
administration. A moderate increase in the liver triglyceride
levels was also found in HF-fed rats in comparison with the
control animals at the fourth week (?38 %), whereas a
strong increase was found at the sixth week (?2.3-fold). On
the contrary, the HC animals showed modest, although sig-
nificant, variations in the liver triglyceride concentrations
only in the first two weeks of dietary treatments. A compa-
rable behavior was observed in the case of the liver
cholesterol levels (Fig. 4b). In fact, the cholesterol concen-
trations more than doubled in HHF-fed animals in compar-
ison with the control rats starting from the second week of
dietary administration. Moreover, also in the HF-fed ani-
mals, a significant increase in the liver cholesterol levels was
reproducibly found at the fourth and the sixth week. On the
contrary, in HC-fed animals, a significant increase in the
levels of liver cholesterol was only found in the first 2 weeks
of dietary treatment (Fig. 4b). No significant variations were
detected in the levels of liver phospholipids in any animal
group (data not shown).
Plasma levels of glucose and insulin
Figure 5a shows that the plasma glucose levels doubled in
HC-fed rats in comparison with the control animals.
Moreover, in the HF- and HHF-fed animals, a significant
increase in the glucose levels was found at any time of
dietary treatment in comparison with the control rats.
However, these increments were lower than those found in
the HC-fed animals. Only at the sixth week, the glucose
levels in the HC-, HF-, and HHF-fed animals were indis-
tinguishable (about 60 % higher than the values found in
control animals). Notably, the variations in the plasma
insulin levels (Fig. 5b) very closely reflected those in
glucose levels (Fig. 5a).
Discussion
The de novo fatty acid synthesis is a metabolic process
actively investigated because its regulation is quite com-
plex and also because its dysregulation may lead to several
diseases. In order to gain more insights into this anabolic
process, we have investigated the effect of three different
diets on rat hepatic lipogenesis.
Table 3 Km and Vmax of citrate transport in a reconstituted system
Km (mM) Vmax (nmol�min-1�mg protein-1)
Control HC HF HHF Control HC HF HHF
Week 0 0.198 – – – 141.73 – – –
Week 1 0.189 0.189 0.190 0.198 143.26 164.75 72.06 32.62
Week 2 0.203 0.211 0.193 0.187 140.96 158.20 77.64 78.51
Week 4 0.203 0.213 0.183 0.184 140.96 159.36 113.40 112.17
Week 6 0.189 0.196 0.187 0.195 141.59 168.07 141.55 145.46
Km and Vmax values were measured in a reconstituted system at the times indicated. Proteoliposomes were reconstituted with the CIC as
described in the ‘‘Methods’’ section. [l4C]Citrate, 0.04–0.40 mM, was added to proteoliposomes containing 10 mM citrate. The citrate/citrate
exchange was stopped 1 min after the addition of the radiolabeled substrate by 20 mM 1,2,3-BTA. Km and Vmax values were calculated by
linear regression
Data correspond to the mean of values obtained in two independent experiments. Differences between values of every couple were less than
10 %
Eur J Nutr
123
Some methodological aspects of this study merit con-
sideration before discussing in details the results obtained.
At first, the feeding treatment of rats with distinct diets,
enriched in sucrose or in fat, has been done in the same
study. This helped us to investigate the differential effects
of carbohydrate, on the one hand, and of fat, on the other
hand, in the same experimental conditions. On the contrary,
general conclusions on diet-induced metabolic changes
have been reached by combining the results obtained in
independent studies, carried out in different experimental
conditions [3, 5, 15, 16]. Secondly, in this study, we
investigated the changes occurring in rat hepatic lipogen-
esis in a feeding period ranging from 1 to 6 weeks, thereby
highlighting the impressive changes of this anabolic path-
way especially in the first week. Third, we have analyzed
the molecular mechanisms of these metabolic changes
involving a strict coordination between mitochondrial and
cytosolic reactions, thus clearly demonstrating a strict
interplay between anabolic and catabolic pathways.
An interesting consideration can be made on body
weight changes. Although the differences were not signif-
icant, there is a clear trend in this study showing that when
the energy content of the diet is higher, the intake of food
becomes lower (Table 2). Although the four groups of
animals ate a similar number of calories, the gains in body
weight were different and the effect is especially evident
for HF and HHF diets, which seem to show a higher
feeding efficiency (weight gain per kcal consumed). In this
case, the reported effects of the increase in dietary fat on
the secretion and signaling of gastrointestinal hormones
may predispose to weight gain and obesity [17].
The enzymatic assays showed the elevated metabolic
flexibility of liver, which was able to quickly modulate the
de novo fatty acid synthesis in relation to the type of diet
ingested. A diet containing 66 % (w/w) sucrose moderately
stimulated hepatic lipogenesis (about ?20 % with respect
to control animals). Similar results were previously
reported in the literature, although a more prominent
increase in hepatic lipogenesis was detected in the first
hours up to a few days after the ingestion of a HC-enriched
diet [15]. However, in most of these studies, the animals
were either first starved for some time [3, 15, 18] or fed
with a high-fat and carbohydrate-free diet [1] before
receiving the HC diet. The HC diet, on the other hand,
contained a low level of fat [3]. All these experimental
expedients significantly emphasized the metabolic changes
due to a HC diet. However, these enzyme hyperinductions,
although important for experimental purposes, have a
scarce significance in the current nutritional models of
western populations. Indeed, the current western dietary
habits generally imply an enrichment in the sucrose of diets
that already contain adequate (or sometimes excessive)
amounts of fat and protein with the consequence of
ingestion of unbalanced diets and/or of excess of calories
[19]. The dietary manipulations reported in our investiga-
tion are more similar to these eating behaviors.
Plasmatic lipid profile of rats fed the HC diet suggested
interesting considerations. As shown in Table 4, in these
animals, the plasma triglyceride levels were significantly
higher than those of control rats in the first 4 weeks of
feeding. A concomitant increase in hepatic lipogenesis and
plasma triglycerides is therefore evident in HC-fed rats.
The increase in the activity of mitochondrial CIC and
lipogenic enzymes ACC and FAS stimulated the synthesis
of fatty acids in liver with a subsequent rise in the level of
plasma triglycerides, as already demonstrated by others
A
B
Fig. 2 Effect of high-carbohydrate and high-fat diets on protein
levels (a) and mRNA (b) of the mitochondrial CIC. The values
reported in the graph represent the mean ± SD (n = 4; *P \ 0.05 vs.
rats fed a control diet; �P \ 0.05 vs. rats fed a HC diet; �P \ 0.05 vs.
rats fed a HF diet). The amount of CIC revealed by immunodeco-
ration and the amount of CIC mRNA at the beginning of dietary
treatment were set to 100 %. The values reported in the graph
represent the mean ± SD (n = 3; *P \ 0.05 vs. rats fed a control
diet; �P \ 0.05 vs. rats fed a HC diet; �P \ 0.05 vs. rats fed a HF diet)
Eur J Nutr
123
[15, 20, 21]. The increase in plasma triglycerides observed
in the present investigation was persistent in the first month
of feeding treatment, thereby substantiating the role of liver
in synthesizing and subsequently distributing lipids to other
tissues by circulation. On the other hand, in our study, no
statistically significant variations in the level of liver lipids
A B
C D
Fig. 3 Effect of high-carbohydrate and high-fat diets on lipogenic
enzyme activities and mRNA levels. The activities of ACC (a) and
FAS (b) were measured in the cytosol of rat hepatocytes at the times
indicated. The values are expressed as nanomoles of NADH (ACC) or
NADPH (FAS) oxidized�min-1�mg protein-1 and represent the
mean ± SD (n = 4; *P \ 0.05 vs. rats fed a control diet;�P \ 0.05 vs. rats fed a HC diet; �P \ 0.05 vs. rats fed a HF diet).
Total RNA from the liver of rats fed the experimental diets was
extracted, and the abundance of ACC (c) and FAS (d) mRNA was
analyzed by RT-quantitative PCR. The amount of ACC and FAS
mRNA revealed at the beginning of dietary treatment was set to
100 %. The values reported in the graph represent the mean ± SD
(n = 3; *P \ 0.05 vs. rats fed a control diet; �P \ 0.05 vs. rats fed a
HC diet; �P \ 0.05 vs. rats fed a HF diet)
Table 4 Plasma triglycerides (mg/dl)
Control HC HF HHF
Mean SD Mean SD Mean SD Mean SD
Week 0 119.0 11.2 – – –
Week 1 125.5 23.0 288.0* 11.6 162.7*� 6.3 260.7*�� 5.4
Week 2 156.3 8.1 260.1* 4.5 171.5� 18.8 154.4� 12.5
Week 4 146.2 8.1 293.0* 43.9 231.6*� 26.8 157.6�� 4.5
Week 6 157.6 13.4 192.4* 26.8 199.4* 8.1 206.3* 1.8
The levels of plasma triglycerides were determined at the times indicated, using commercial kits. The values reported in the table represent the
mean ± SD (n = 4)
* P \ 0.05 versus rats fed a control diet; � P \ 0.05 versus rats fed a HC diet; � P \ 0.05 versus rats fed a HF diet
Eur J Nutr
123
have been found in HC-fed rats. Indeed, only a moderate,
but statistically significant, increase in triglyceride and
cholesterol levels was found in the first 2 weeks of HC diet
feeding.
A strong inhibition of lipogenic enzyme expression and
activity was instead found in rats fed with a diet enriched in
fat. Two fat-rich diets were used, one containing 20 % (w/w)
and the other 35 % (w/w) fat. The de novo fatty acid syn-
thesis inhibition induced by these experimental diets was
particularly strong in the first week of dietary treatment. This
inhibition progressively decreased over time and was com-
pletely abolished at the sixth week of dietary treatment. A
similar time dependence of lipogenesis inhibition was
recently found in another study [22]. Furthermore, we found
that the degree of inhibition was also dependent on the
amount of dietary fat (about 80–90 and 50–55 % inhibition at
35 and 20 % (w/w) dietary fat, respectively). By further
lowering the total level of dietary fat, only diets enriched in
PUFA were able to significantly reduce hepatic lipogenesis
[6, 23–27]. The PUFA-mediated inhibition of hepatic lipo-
genesis was also observed when rats were fed, over the long
term, with a high-fat (45 % of calories) diet. In these animals,
a decrease in the amount of mRNA coding for hepatic lipo-
genic enzymes was found in comparison with the rats fed
with an isocaloric diet rich in saturated fatty acids [28]. On
the other hand, it has been shown that an excessive level of
dietary fat counteracts the differential effect of the various
types of fatty acids on hepatic lipogenesis, thereby resulting
in a massive inhibition of hepatic lipid metabolism [16].
Therefore, the effects of dietary fat on hepatic lipogenesis
were dependent on a series of factors, not only the amount of
fat in the diet, but also the fatty acid composition, the length,
and the characteristics of feeding treatment (i.e., feeding
ad libitum or fasting and refeeding) and the animal species
tested [4, 5, 29].
A
B
Fig. 4 Effect of high-carbohydrate and high-fat diets on liver lipids.
The levels of liver triglycerides (a) and cholesterol (b) were
determined at the times indicated. Each point represents the
mean ± SD for 4 liver samples. *P \ 0.05 versus rats fed a control
diet; �P \ 0.05 versus rats fed a HC diet; �P \ 0.05 versus rats fed a
HF diet
A
B
Fig. 5 Effect of high-carbohydrate and high-fat diets on plasmatic
levels of glucose and insulin. a Plasma glucose concentrations were
determined using a commercial kit. b Plasma insulin concentrations
were analyzed with commercial enzyme-linked immunosorbent assay
kits. The values reported in the figure represent the mean ± SD
(n = 4). *P \ 0.05 versus rats fed a control diet; �P \ 0.05 versus
rats fed a HC diet; �P \ 0.05 versus rats fed a HF diet
Eur J Nutr
123
Notably, in the present study, parallel inhibitions of
mitochondrial CIC and cytosolic ACC and FAS were
found, thus suggesting a concerted network of regulation
that starts from substrate exit from mitochondria and
propagate to cytosolic anabolic reactions. This type of
concerted inhibition of mitochondrial and cytosolic reac-
tions was also found in starved rats [30]. The intricacy of
these regulations is also corroborated by the fact that ACC
plays a crucial role in the de novo lipogenesis because its
product, malonyl-CoA, is not only an intermediate of fatty
acid synthesis but also an inhibitor of carnitine palmitoyl-
transferase (CPT-1) and therefore an inhibitor of fatty acid
oxidation [31]. Moreover, plasma triglycerides more than
doubled in HHF animals at the first week of feeding but
after that decreased to control values at the second week
(Table 4).
The high level of circulating triglycerides found only at
the first week in the HHF group cannot be due to an
increased de novo fatty acid synthesis because the activities
of both mitochondrial CIC and ACC/FAS were profoundly
depressed in these animals at that time (Figs. 1, 3).
Therefore, these triglycerides are of exogenous origin,
most probably deriving from the high fat content of the diet
administered to these animals. On the other hand, it is
particularly evident that the extremely high amount of
triglycerides was found in liver, starting from the second
week of feeding. In principle, this elevated level of lipid in
liver, reported in this and in other studies [22, 32–34], can
be caused by several factors, such as an increased uptake
and esterification of fatty acids from dietary sources, an
increased de novo fatty acid synthesis and a decreased fatty
acid oxidation. The strong inhibition of hepatic lipogenesis
occurring in HHF-fed rats (Figs. 1, 2, 3) suggests that liver
may represent an energy storage for fat of exogenous ori-
gin. It is also surprising to observe in HHF animals that
when plasma triglycerides are high (first week), liver tri-
glycerides are low, whereas the opposite happens at longer
times of feeding, that is, a great accumulation of fat in liver
and a normalization of triglyceride levels in plasma. Fur-
thermore, in these animals, the same trend is observed for
cholesterol, that is, a moderate yet significant increase
(P \ 0.05 vs. rats fed a control diet) in its level in plasma
at the first week, followed by a normalization at longer
times. On the contrary, a specular trend was observed in
TRIGLYCERIDES
CHOLESTEROL
CIC
Citrate
Acetyl-CoAOAA
Palmitic acid
ACC
FAS
Citrate
Glucose
Pyruvate
Pyruvate
OAAAcetyl-CoA +
Liver mitochondria
LIPOGENESISLIPOGENESIS
GLUCOSE
INSULIN
TRIGLYCERIDES
HC diet HF diet
Liver
BloodFig. 6 Metabolic pathways
influenced by high carbohydrate
and high-fat diets. Metabolic
changes occurring in rats under
the different nutritional
conditions used in this study.
OAA oxaloacetate
Eur J Nutr
123
liver, where only from the second week onward, an accu-
mulation of hepatic cholesterol was clearly observed.
Actually, the metabolic changes occurring in liver may be
more complicated than those described. In fact, the
increase in liver triglycerides starting from the second
week, most probably due to an accumulation of exogenous
lipids of dietary origin, can also derive, at least in part,
from a progressive reversal of lipogenesis inhibition.
An increase in the plasmatic levels of glucose and
insulin was observed in all the feeding conditions used
in this study, even if the highest increase was seen in the
case of the HC diet, especially in the first month of
treatment. The parallel increase in glucose and insulin in
the case of HC-fed rats is easily explained by the ele-
vated content of sucrose of this type of diet. On the
other hand, the high plasmatic level of glucose and
insulin in HF- and HHF-fed animals can be due to a
lower utilization of glucose when diets are strongly
enriched in fat, suggesting a condition of insulin resis-
tance [35, 36]. An excess of energy supplied by fat
corresponds to a scarce tissutal utilization of glucose,
thereby causing hyperglycemia and hyperinsulinemia.
Moreover, it has also been reported that an excess of
circulating free fatty acids, whose concentration was
significantly greater in animals fed a HF or a HC diet
[37], may contribute to insulin resistance [38].
Conclusions
Figure 6 illustrates the metabolic changes occurring in
liver of rats under the different nutritional conditions
used in this study. The changes occurring in the level of
circulating lipids are also illustrated. A diet enriched in
sucrose, but containing adequate amounts of protein and
fat, moderately stimulates hepatic lipogenesis. Modest
and transient increments in the levels of triglycerides and
cholesterol were observed in liver, whereas a strong
increase in triglycerides was found in plasma. This
suggests that the excess of sucrose is converted into fat
and that this fat (i.e., circulating triglycerides) is dis-
tributed by bloodstream in the organism. On the con-
trary, a diet enriched in fat, but containing adequate
amounts of carbohydrate and protein, caused a strong
inhibition of lipogenesis, especially at the beginning of
this dietary treatment (first 2 weeks). A time-dependent
reversal of this inhibition was then progressively found.
Starting from the second week of feeding, a prominent
increase in the level of hepatic triglycerides and cho-
lesterol was observed. Interestingly, a rapid increase in
the levels of circulating lipids was only found at the first
week of dietary treatment. Liver, therefore, appears as a
compensating reservoir of exogenous lipids in conditions
of inhibited de novo lipogenesis.
The overall picture emerging from this investigation
shows a prompt metabolic flexibility of hepatic fatty acid
synthesis in the dependence of the characteristics of the
diet and, in particular, of the amount and quality of the
nutrients introduced.
Conflict of interest None.
Ethics statement This study was carried out in strict accordance
with the European Committee Council 106 Directive (86/609/EEC)
and with the Italian animal welfare legislation (art 4 and 5 of D.L.
116/92). The Italian Ministry of Health specifically approved this
study.
References
1. Girard J, Perdereau D, Foufelle F, Prip-Buus C, Ferre P (1994)
Regulation of lipogenic enzyme gene expression by nutrients and
hormones. FASEB J 8:36–42
2. Strable MS, Ntambi JM (2010) Genetic control of de novo
lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol
Biol 45:199–214
3. Kim TS, Freake HC (1996) High carbohydrate diet and starvation
regulate lipogenic mRNA in rats in a tissue-specific manner.
J Nutr 126:611–617
4. Hill R, Linazasoro JM, Chevallier F, Chaikoff IL (1958) Regu-
lation of hepatic lipogenesis: the influence of dietary fats. J Biol
Chem 233:305–310
5. Sabine JR, McGrath H, Abraham S (1969) Dietary fat and the
inhibition of hepatic lipogenesis in the mouse. J Nutr 98:312–318
6. Triscari J, Hamilton JG, Sullivan AC (1978) Comparative effects
of saturated and unsaturated lipids on hepatic lipogenesis and
cholesterogenesis in vivo in the meal-fed rat. J Nutr 108:815–825
7. Palmieri F, Stipani I, Quagliariello E, Klingenberg M (1972)
Kinetic study of the tricarboxylate carrier in rat-liver mitochon-
dria. Eur J Biochem 26:587–594
8. Zara V, Iacobazzi V, Siculella L, Gnoni GV, Palmieri F (1996)
Purification and characterization of the tricarboxylate carrier
from eel liver mitochondria. Biochem Biophys Res Commun
223:508–513
9. Palmieri F (2004) The mitochondrial transporter family (SLC25):
physiological and pathological implications. Pflugers Arch
447:689–709
10. Palmieri F, Bisaccia F, Capobianco L, Iacobazzi V, Indiveri C,
Zara V (1990) Structural and functional properties of mitochon-
drial anion carriers. Biochim Biophys Acta 1018:147–150
11. Bradford MM (1976) A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein-dye binding. Anal Biochem 72:248–254
12. Dulley JR, Grieve PA (1975) A simple technique for eliminating
interference by detergents in the Lowry method of protein
determination. Anal Biochem 64:136–141
13. Ferramosca A, Savy V, Conte L, Colombo S, Einerhand AW,
Zara V (2006) Conjugated linoleic acid and hepatic lipogenesis in
mouse: role of the mitochondrial citrate carrier. J Lipid Res
47:1994–2003
14. Damiano F, Gnoni GV, Siculella L (2009) Functional analysis of
rat liver citrate carrier promoter: differential responsiveness to
polyunsaturated fatty acids. Biochem J 417:561–571
Eur J Nutr
123
15. Bruckdorfer KR, Khan IH, Yudkin J (1972) Fatty acid synthetase
activity in the liver and adipose tissue of rats fed with various
carbohydrates. Biochem J 129:439–446
16. Tovar AR, Dıaz-Villasenor A, Cruz-Salazar N, Ordaz G, Gra-
nados O, Palacios-Gonzalez B, Tovar-Palacio C, Lopez P, Torres
N (2011) Dietary type and amount of fat modulate lipid metab-
olism gene expression in liver and in adipose tissue in high-fat
diet-fed rats. Arch Med Res 42:540–553
17. Little TJ, Horowitz M, Feinle-Bisset C (2007) Modulation by
high-fat diets of gastrointestinal function and hormones associ-
ated with the regulation of energy intake: implications for the
pathophysiology of obesity. Am J Clin Nutr 86:531–541
18. Iritani N (1992) Nutritional and hormonal regulation of lipogenic-
enzyme gene expression in rat liver. Eur J Biochem 205:433–442
19. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Wat-
kins BA, O’Keefe JH, Brand-Miller J (2005) Origins and evo-
lution of the Western diet: health implications for the 21st
century. Am J Clin Nutr 81:341–354
20. Naismith DJ, Rana IA (1974) Sucrose and hyperlipidaemia.
I. The relationship between the plasma lipid concentrations and
enzymes of tissue lipogenesis. Nutr Metab 16:238–248
21. Ryu MH, Cha YS (2003) The effects of a high-fat or high-sucrose
diet on serum lipid profiles, hepatic acyl-CoA synthetase, carni-
tine palmitoyltransferase-I, and the acetyl-CoA carboxylase
mRNA levels in rats. J Biochem Mol Biol 36:312–318
22. Ferramosca A, Conte A, Burri L, Berge K, De Nuccio F, Giudetti
AM, Zara V (2012) A krill oil supplemented diet suppresses
hepatic steatosis in high-fat fed rats. PLoS ONE 7(6):e38797
23. Clarke SD, Romsos DR, Leveille GA (1977) Differential effects
of dietary methyl esters of long-chain saturated and polyunsatu-
rated fatty acids on rat liver and adipose tissue lipogenesis. J Nutr
107:1170–1181
24. Flick PK, Chen J, Vagelos PR (1977) Effect of dietary linoleate
on synthesis and degradation of fatty acid synthetase from rat
liver. J Biol Chem 252:4242–4249
25. Siculella L, Sabetta S, Damiano F, Giudetti AM, Gnoni GV
(2004) Different dietary fatty acids have dissimilar effects on
activity and gene expression of mitochondrial tricarboxylate
carrier in rat liver. FEBS Lett 578:280–284
26. Ferramosca A, Savy V, Zara V (2008) Olive oil increases the
hepatic triacylglycerol content in mice by a distinct influence on
the synthesis and oxidation of fatty acids. Biosci Biotechnol
Biochem 72:62–69
27. Ferramosca A, Conte L, Zara V (2012) A krill oil supplemented
diet reduces the activities of the mitochondrial tricarboxylate
carrier and of the cytosolic lipogenic enzymes in rats. J Anim
Physiol Anim Nutr 96:295–306
28. Shillabeer G, Hornford J, Forden JM, Wong NC, Lau DC (1990)
Hepatic and adipose tissue lipogenic enzyme mRNA levels are
suppressed by high fat diets in the rat. J Lipid Res 31:623–631
29. Herzberg GR, Janmohamed N (1980) Regulation of hepatic
lipogenesis by dietary maize oil or tripalmitin in the meal-fed
mouse. Br J Nutr 43:571–579
30. Zara V, Gnoni GV (1995) Effect of starvation on the activity of
the mitochondrial tricarboxylate carrier. Biochim Biophys Acta
1239:33–38
31. Kim KH (1997) Regulation of mammalian acetyl-coenzyme A
carboxylase. Annu Rev Nutr 17:77–99
32. Basaranoglu M, Kayacetin S, Yilmaz N, Kayacetin E, Tarcin O,
Sonsuz A (2007) Understanding mechanisms of the pathogenesis
of nonalcoholic fatty liver disease. World J Gastroenterol
16:2223–2236
33. Marecki JC, Ronis MJ, Shankar K, Badger TM (2011) Hyper-
insulinemia and ectopic fat deposition can develop in the face of
hyperadiponectinemia in young obese rats. J Nutr Biochem
22:142–152
34. Flamment M, Rieusset J, Vidal H, Simard G, Malthiery Y,
Fromenty B, Ducluzeau PH (2012) Regulation of hepatic mito-
chondrial metabolism in response to a high fat diet: a longitudinal
study in rats. J Physiol Biochem 68:335–344
35. Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H,
Ezaki O (1996) High-fat diet-induced hyperglycemia and obesity
in mice: differential effects of dietary oils. Metabolism
45:1539–1546
36. Bisschop PH, de Metz J, Ackermans MT, Endert E, Pijl H, Ku-
ipers F, Meijer AJ, Sauerwein HP, Romijn JA (2001) Dietary fat
content alters insulin-mediated glucose metabolism in healthy
men. Am J Clin Nutr 73:554–559
37. Sumiyoshi M, Sakanaka M, Kimura Y (2006) Chronic intake of
high-fat and high-sucrose diets differentially affects glucose
intolerance in mice. J Nutr 136:582–587
38. Arner P (2002) Insulin resistance in type 2 diabetes: role of fatty
acids. 18. Diabetes Metab Res Rev 18(Suppl 2):S5–S9
Eur J Nutr
123